Join a COVID-19 clinical trial
The PRINCIPLE trial aims to find treatments that reduce hospital admission and improve symptoms for people with COVID-19. You could be eligible to join if
- You have had these symptoms for fewer than 15 days:
- a continuous new or worsening cough
- a high temperature
- OR have a positive test for SARS-Co-V2 infection with COVID-19 symptoms in the past 14 days
- You are aged 50 to 64 with a pre-existing illness
- You are aged 65 and above
· To find out more please visit www.principletrial.org or Tel: 0800 138 0 880
Research in the NHS helps us increase our knowledge about human health and wellbeing so we can:
· Develop life changing treatments
· Diagnose disease earlier and more accurately
· Prevent people from developing conditions
· Improve health and care for future generations
· Improve quality of life for all people
You may be approached by your GP practice about a study if you meet the eligibility criteria for the trial. Over the past couple of years we have undertaken studies for patients with a number of conditions including stroke, chronic kidney disease, diabetes, chronic obstructive pulmonary disease (COPD) as well as for indigestion and reflux. If you do receive an invitation to take part in a study the research team at Suffolk Primary Care are very happy to talk to you about the study in more detail and provide further information if you are interested in taking part.
Clinical research studies that Suffolk Primary Care practices are currently involved in:
ATTACK Aspirin to target arterial events in Chronic Kidney Disease is a randomised trial run by the University of Southampton to assess the effectiveness of low-dose aspirin to prevent cardiovascular disease in adult patients with reduced kidney function who have not previously had a heart attack or stroke. The aim of the study is to determine whether the benefits of aspirin outweighs any risks in this group of patients. This study has come as a result of recommendations for research in the 2014 NICE CKD Guidelines and it is anticipated that over 25,000 people will be recruited to the study across the UK. This study is being run in all of our of Suffolk Primary Care practices in a rolling programme.
Glucose Lowering through Weight Management. The University of Cambridge GLoW (Glucose Lowering through Weight management) trial is aimed at people who have been diagnosed with Type 2 diabetes within the last three years. The GLoW trial will evaluate two programmes which support people with Type 2 Diabetes to improve their diet and physical activity to improve their health. The evidence is that people who lose weight, improve their diet and increase their physical activity reduce the risk of developing health problems associated with diabetes such as heart attack and stroke. The aim of the GLoW study is to determine which programme is the better way for the NHS to improve patient’s health.
How to find out more about research:
‘Be part of research’ helps you find out about health and social care research that is taking place across the UK and provides opportunities to take part in research.
Dementia affects more than 850,000 people in the UK. Research is the best way to make a difference. Registering with Join Dementia Research is the first step to getting involved in supporting research studies across the UK. Anyone over the age of 18 can sign up, including:
- People with dementia or memory problems
- Carers for people with dementia or memory problems
- Anyone else who is interested
You can also sign up on behalf of someone else, providing that you have their consent.